| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |